NURSING HOME MEDICATION ERROR QUALITY INITIATIVE (MEQI) JANUARY 1, 2004 TO SEPTEMBER 31, 2004

Similar documents
Nursing Home Medication Error Quality Initiative

Pharmaceutical Services Report to Joint Conference Committee September 2010

The CMS State Operations Manual Overview and Changes

Medication Safety Dashboard

Using MEDMARX for Reporting and Benchmarking. Anne Skinner, RHIA Katherine Jones, PhD, PT

PO Box 6609 Helena, MT Phone: (800) Fax: (406)

Alabama Medicaid Pharmacy Override

Monitoring Medication Storage & Administration

Improving Safety Practices Anticoagulation Therapy

Medication Safety Action Bundle Adverse Drug Events (ADE) All High-Risk Medication Safety

Nurse Orientation. Medication Management

Drug Events. Adverse R EDUCING MEDICATION ERRORS. Survey Adapted from Information Developed by HealthInsight, 2000.

MEDICATION USE EFFECTIVE DATE: 06/2003 REVISED: 2/2005, 04/2008, 06/2014

Legal Risk Management Opportunities, Pharmacy Practice, and P&T Committees

Update on Pharmacy Issues in Long Term Care Lisa Nichols RPh, CGP

SHRI GURU RAM RAI INSTITUTE OF TECHNOLOGY AND SCIENCE MEDICATION ERRORS

Constant Pursuit of Medication Safety. Geraldine Koh Chief Pharmacist

POLICY. Use of Antipsychotic Medications in Nursing Facility Residents. Preamble. Background

DEPARTMENT OF HEALTH AND HUMAN SERVICES CENTERS FOR MEDICARE & MEDICAID SERVICES Medication Administration Observation

PERFORMANCE MEASURE DATE / RESULTS / ANALYSIS FOLLOW-UP / ACTION PLAN

University of Wisconsin Hospital and Clinics Medication Reconciliation Education Packet

Preventing Medical Errors Presented by Debra Chasanoff, MEd, OTR/L FOTA Annual Conference, November 4-5, 2016

Preventing Medical Errors Presented by Debra Chasanoff, MEd, OTR/L FOTA Annual Conference November 3, 2017

COMPASS Phase II Incident Analysis Report Prepared by ISMP CANADA February 2016

BPOC/eMAR Spotlight on Performance Improvement

CRAIG HOSPITAL POLICY/PROCEDURE

Welcome to the New England QIN-QIO Medication Safety Webinar!

Thoracic surgery medicines

Importance of Clinical Leadership in Pharmacy

DEPARTMENT OF HEALTH AND HUMAN SERVICES CENTERS FOR MEDICARE & MEDICAID SERVICES

Section 1: Introduction to Medication Assistance

Organization: Solution Title: Program/Project Description, including Goals: What is this project? Why is this project important?

The Focused Survey. Coleen Kayden, RPh Medication Information Services Division of Williams Apothecary Lancaster, PA

University of Mississippi Medical Center University of Mississippi Health Care. Pharmacy and Therapeutics Committee Medication Use Evaluation

MEDICATION ASSISTANCE GUIDELINES: TEACHING PLAN

Thanks to Anne C. Byrne, RN, Medical Monitor at Northwest Georgia Regional Hospital. This presentation was developed from one she designed for that

SAINT BARNABAS HEALTH CARE SYSTEM Preparation for Nursing Pharmacology Test PHARMACOLOGY REVIEW GUIDE

PRESCRIPTION MONITORING PROGRAM USING THE CONNECTICUT PRESCRIPTION MONITORING AND REPORTING SYSTEM (CPMRS)

Critical Access Hospitals Site Visit Summary Tom Johns, PharmD, BCPS Director, Pharmacy Services UF Health Shands Hospital

Pharmacy Services. Division of Nursing Homes

Ensuring our safeguarding arrangements act to help and protect adults PRACTICE GUIDANCE FOR REPORTING MEDICATION INCIDENTS INTO SAFEGUARDING

Be comfortable with comfort Meds

Pharmacology (PHA 321)

IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF FLORIDA PANAMA CITY DIVISION COUNTS ONE THROUGH ONE HUNDRED. A.

Testing the Effects of Nursing Education on Pharmacodynamics in the Elderly: The Impact on Fall Rates. Joanne Zanetos DNP MSN/Ed RN

Medication Reconciliation

SPSP Medicines. Prepared by: NHS Ayrshire and Arran

Long-Term Care Medication Management: A Demonstration Project. Training Support Deck July 2016

PHARMACY SERVICES/MEDICATION USE

Patterns in nursing home medication errors: disproportionality analysis as a novel method to identify quality improvement opportunities

Kansas Nursing Home Medication Aide Curriculum Guide

Medication Administration & Preventing Errors M E A G A N R A Y, R N A M G S P E C I A L T Y H O S P I T A L

A Million Little Pieces: Developing a Controlled Substance Diversion Program. Tanya Y. Barnhart, PharmD, BCPS

Storage, Labeling, Controlled Medications Instructor s Guide CFR (b)(2)(3)(d)(e) F431

APPENDIX 8-2 CHECKLISTS TO ASSIST IN PREVENTING MEDICATION ERRORS

Hospital Guidance Webinar

WHAT are medication errors?

A Guide to Accessing Psychiatric Medications

Deprescribing: Importing Innovations from Outside the US A27 and B27

Oxfordshire Anticoagulation Service. Important information about anticoagulation with vitamin K antagonists Information for patients

H2H Mind Your Meds "Challenge. Webinar #3- Lessons Learned Wednesday, April 18, :00 pm 3:00 pm ET. Welcome

(b) Is administered via a transdermal route; or

Walking the Tightrope with a Safety Net Blood Transfusion Process FMEA

3/9/2010. Objectives. Pharmacist Role in Medication Safety and Regulatory Compliance

Medication Reconciliation

Ontario Hospital Critical Incidents Related to Medications or IV Fluids Analysis Report. October 2011 to December 2012

diabetes care and quality improvement in our practice

PHARMACIST HEALTH COACHING CARDIOVASCULAR PROGRAM. 1. Introduction. Eligibility Criteria

Center for Clinical Standards and Quality/Survey & Certification Group

PERFORMANCE IMPROVEMENT REPORT

Running head: MEDICATION ERRORS 1. Medications Errors and Their Impact on Nurses. Kristi R. Rittenhouse. Kent State University College of Nursing

OKLAHOMA. Downloaded January 2011

Medication Adherence

Medication Use Evaluation and Cost Minimization Analysis of Injectable Nicardipine in a Community Hospital

On September 4, 2012, the evening shift supervisor called the

Guidelines on Medication Administration for School Personnel

Patient Safety in Ambulatory Care: Why Reporting Counts. August 11, 2010 Diane Schultz, RPh and Sheila Yates, MPH

CHAPTER 9 PERFORMANCE IMPROVEMENT HOSPITAL

Social care guideline Published: 14 March 2014 nice.org.uk/guidance/sc1

Medication Diversion and Prescription Drug Abuse in the Long Term Care Setting. Objectives

McMinnville School District #40

CAYUGA COMMUNITY COLLEGE DEPARTMENT OF NURSING COURSE SYLLABUS NURSING Credit Hours. 3 hrs/wk x 15 wks hrs...

Medication Related Changes Phase 1&2

FIRST PATIENT SAFETY ALERT FROM NATIONAL PATIENT SAFETY AGENCY (NPSA) Preventing accidental overdose of intravenous potassium

Improving the Pre-Empted Medication Error Reporting System at St. Charles Hospital, Port Jefferson, NY

AT THIS TIME, PLEASE COMPLETE THE PRE TEST FOUND AT THE END OF THIS DOCUMENT.

C HAPTER 5 D RUG ORDERS

Medication Safety & Electrolyte Administration. Objectives. High Alert Medications. *Med Safety Electrolyte Administration

Medication Errors in Chemotherapy PORSCHA L. JOHNSON, PHARM.D. CLINICAL PHARMACIST II MEDSTAR WASHINGTON HOSPITAL CENTER SATURDAY, SEPTEMBER 17, 2016

INPATIENT UNIT MEDICATIONS. Best Practice Guidelines

Managing Pharmaceuticals to Reduce Medication Errors August 26, 2003

INTRODUCTION Reduce falls Improve patient outcomes Establish a baseline of falls in home care

Improvement Activities for ACI Bonus Measures

High Alert Medications: Reducing Patient Harm

Examples of enforcement letters to Adult Family Homes certified to care for people with Developmental Disabilities in Washington State

Medication Reconciliation: Using Pharmacy Technicians to Improve Care. Becky Johnson, CPhT Megan Ohrlund, PharmD Steve Finch, RPh

Medication Reconciliation: Using Pharmacy Technicians to Improve Care. Objectives THE BASICS AND USING TECHNICIANS 3/22/2017

Medication Trauma Crisis: Primary Care Innovations. Session Code: D25, E25

Managing medicines in care homes

Medical Intensive Care Unit Rotation EUHM

Transcription:

NURSING HOME MEDICATION ERROR QUALITY INITIATIVE (MEQI) JANUARY 1, 2004 TO SEPTEMBER 31, 2004 Sandra B. Greene, DrPH; Charlotte E. Williams, MPH; Richard Hansen, PhD; Kathleen D. Crook, MPA; Roger Akers MSIS; Melissa G. Butler, PharmD, MPH, BCPS and Timothy S. Carey, MD, MPH I. NORTH CAROLINA SENATE BILL 1016 In 2003, the North Carolina General Assembly passed Senate Bill 1016 addressing medication management in the State s nursing homes and requiring an annual report of medication errors. The bill is entitled: An Act requiring nursing homes to establish a medication management advisory committee and specifying the duties of the committee and to require nursing homes to do certain things pertaining to the reduction of medication-related errors to increase patient safety. The purpose of the bill is to promote the use of a medication management advisory committee in each nursing home that will oversee the reporting of medication errors and the evaluation of their cause. Follow up action by each facility s committee is intended to reduce subsequent errors and enhance patient safety. II. PROGRAM OVERVIEW In early 2004, the State of North Carolina contracted with the Cecil G. Sheps Center for Health Services Research (Sheps Center) at The University of North Carolina at Chapel Hill to implement a Medication Error Quality Initiative (MEQI) as part of Senate Bill 1016. The MEQI requires that each nursing home report, on an annual basis, information about medication errors that occur in its facility. The first annual report includes only nine months (January 1, 2004 to September 31, 2004) of medication error experience. Subsequent reports will include 12 months of errors. The reporting is mandatory for all nursing homes, but is limited to self-report. At this time no on-site review or follow-up to ensure the accuracy of these reports is required. Definition of a Medical Error for the Purposes of the MEQI: The term error for the purposes of reporting includes errors that did not reach the patient, or did not harm the patient. This would include near misses where the error is caught before it occurs, and situations that could lead to error and dose omissions. The goal of such reporting is for facilities to examine how all errors occur and make appropriate changes in the medication process on site as problem areas are identified. It is to be expected that a nursing home that is being careful about reporting and recording errors would have a significant number of errors to report, and we commend this effort. Prepared by the Cecil G. Sheps Center for Health Services Research at The University of North Carolina at Chapel Hill under contract for the North Carolina Department of Health and Human Services, Division of Facility Services.

Nursing Home Medication Error Quality Initiative (MEQI) III. DATA COLLECTION With assistance from a statewide group of nursing home representatives, pharmacists and such agencies as the North Carolina Health Care Facilities Association (NCHCFA), the Sheps Center developed an individual medication error data collection form. This form was sent to all 386 licensed nursing homes in April 2004 as a suggested tool for tracking individual errors throughout the reporting period. Nursing Homes were surveyed regarding their technical capability. All but five nursing homes had Internet access and the ability to complete an online web-based form. The Sheps Center then developed an online annual report form for facilities to report their aggregate year-end information. The annual report contains the following information: the total number of medication-related errors for the preceding year, a listing of the types of medication-related errors, staff involved, a listing of the types of injuries caused and the number of injuries occurring, and the number of liability claims filed based on an adverse incident or reportable injury. Nursing homes were asked to list ten medications by generic name that were involved in errors at their site. To ensure that no identifying information about an individual patient was revealed, all information in the annual report is reported in a summary form at the facility level. In late September, an annual report packet was mailed to each nursing home with instructions for completing the annual report, along with the form website address, and a randomized facility ID number. Sites were given one month to complete data entry. Facilities that did not respond were sent frequent reminders and updates to encourage data entry. At 15 days after deadline, a 100% response rate was achieved. IV. NURSING HOMES RESPONSE North Carolina currently has 390 licensed nursing homes that fall under requirements for reporting. We received annual reports from 385 facilities, which is 100% of the nursing homes that were open at the beginning of the reporting period and functional during that time. This 100% participation rate is a credit to the nursing homes for making a strong effort to participate in the annual report process. One nursing home was excluded as it had been closed and evacuated due to hurricane flooding, and four new sites were excluded because they were not open the entire year (partial year reports were received from two new sites). This report includes only facilities regulated as nursing homes and excludes those regulated as part of hospitals or hospital systems, and those that are federally funded and regulated. V. DATA SUMMARY AND DISCUSSION All data were provided to the Sheps Center in summary form with no individual or patient level information. The purpose of the legislation and reporting of errors is to encourage the formation of the medication management advisory committee to study errors and address facility processes. TABLE 1: ERROR STATEWIDE SUMMARY NINE MONTH REPORTING PERIOD Total Number of Errors 10,920 Errors that did not reach/did not harm the patient 9,951 Errors that required monitoring / intervention 886 Errors causing temporary harm / require E.R.visit 82 Errors contributing to permanent harm 1 Mean number of errrors/facility 28.4 Median number of errors/facility 15.0 Number of errors per 100 nursing home beds 22.4 2 A. TOTAL ERRORS The total number of errors reported by the 385 nursing homes for the period January 1, 2004 to September 31, 2004 (9 months) was 10,920 (Table 1). Again, these errors include those that actually occurred and near misses with the error being caught prior to reaching the patient. Out of the 10,920 statewide errors, only 886 led to a situation that required monitoring and intervention, and in only 82 of these error occurrences was there temporary harm or harm that required a trip to the emergency room. Only 1 error in the entire State contributed to permanent harm to a resident. In all other errors (9,951) either the error did not reach the patient or did not harm the patient.

The mean number of errors per nursing home was 28.4, the median was 15, and the number of errors per 100 nursing home beds was 22.4. The largest number of facilities, 95, reported between 6 and 10 errors per hundred beds, while only 30 facilities reported over 50 errors per 100 beds (Figure 1). (The nursing homes in the State of North Carolina range in size from 24 to 360 beds, with an average bed size of 121 beds.) A significant range in the number of errors reported per site was observed: three sites reported no errors while one site reported more than 1,000 errors. The number of errors reported per month increased over the year as facilities became aware of the program (Figure 2). Information was also requested on the number of liability claims filed during the reporting period. Zero liability claims were reported. Number of Errors 1,800 1,600 1,400 1,200 1,000 800 600 400 200 Number of Nursing Homes FIGURE 2: ERRORS REPORTED PER MONTH JANUARY 2004 TO SEPTEMBER 2004 Senate Bill 1016 becomes law Form and info mailed to nursing homes 0 Jan. Feb. Mar. Apr. May Jun. Jul. Aug. Sep. 100 90 80 70 60 50 40 30 20 10 0 Nursing Home Medication Error Quality Initiative (MEQI) FIGURE 1: NUMBER OF ERRORS PER 100 BEDS/ < 5 6-10 11-15 16-20 21-25 26-30 31-35 NINE MONTHS 36-40 Error Rate/100 beds 41-45 46-50 51-55 56-60 61-65 66-70 71-75 76-80 81-85 86-90 91-95 96-100 100+ To put the 10,920 errors in context with respect to the opportunities, we estimate the following: The average nursing home resident receives 8.1 medications administered 2.1 times per day (2003 National Medication Usage Study). For the approximately 47,000 nursing home beds in the State of North Carolina this translates to approximately 836,600 administrations of medication per day statewide. Our data has shown an average of 40.5 MEQI errors reported statewide per day, which is a very small percent (only.005%) of medication administration opportunities. We anticipated a large variation in the number of errors reported among the individual sites during the first year due to a lack of consistency in how errors were defined or reported, and this was the case. Data suggest that sites with a large number of errors track a more significant number of near misses and are focused on recording and correcting these events. Sites with smaller numbers or no errors are less likely to have a process in place for recognizing errors, or have decided that certain common occurrences (missed dose, late dose, near misses) are not actually errors. Over the next year, we hope to achieve greater consistency in the implementation of the operational definition of medication errors by working with the reporting facilities and encouraging them to work with one another on the results they are observing. 3

Nursing Home Medication Error Quality Initiative (MEQI) B. COGNITIVE ABILITY Nursing homes were asked to indicate the number of errors that occurred among residents who were able to direct their own care. The definition provided of those who were unable to direct their own care would include those who are demented, comatose, or seriously vision or hearing impaired. Reports show that only 24.7% of errors occurred in those able to direct their own care and consequently, the vast majority of errors impacted patients who were unable to direct their own care. C. PATIENT OUTCOMES All errors were categorized with respect to the patient s outcome (Figure 3). Most of the errors were categorized as either did not reach the patient, (N=1881; 17.2%), or did not harm the patient (N=8,070; 73.9%). Dose omissions were considered to have a potential impact on the patient, even if no harm occurred, and were placed in the category did not harm the patient. A total of 886 (or 8.1% of the errors) led to a situation where the resident required monitoring or intervention to preclude harm. A smaller number of errors (N=59; 0.5%) contributed to temporary harm to the resident. Twenty-three FIGURE 3: PATIENT OUTCOMES Required monitoring and intervention 8.1% Did not harm the patient Contributed to temporary harm 0.5% Temporary, required emergency dept. 0.2% 73.9% Additional categories: Contributed to Permanent Harm (1 error), Intervention Necessary to Sustain Life (0 errors), and Contributed to Patient's Death (0 errors). Did not reach the patient 17.2% errors (0.2%) required a trip to the emergency department. Only one error out of the entire state was described as contributing to permanent harm to an individual. No errors reported required interventions necessary to sustain life or contributed to a patient s death. About 91.1% of the errors reported were in the first two categories, indicating that the error did not reach or did not harm the patient. This annual report includes self-report of all errors, which includes near misses, situations that could lead to error, and includes dose omissions. The goal of such reporting is for facilities to examine how all errors occur and make appropriate changes in the medication process on site as problem areas are identified. D. EFFECTS OBSERVED Respondents were also asked what effects the medication error had on the patient, and could choose multiple responses (Table 2). Effects observed primarily fell in the category that no injury occurred (91.1% of responses), with inadequate effect of product being the second most common response (5.4%). There is internal consistency in that 91.1% of errors have no injury occurred, and 91.1% also fall under the category of did not reach or did not harm the patient. E. TYPE OF VARIANCE The respondents were asked to categorize the type of variance (what kind of error was made), and were permitted to respond in more than one category (Figure 4). The primary type of TABLE 2: TYPE OF EFFECTS Type of Effects No. of Responses Percent Response No injury occurred 10,280 91.1% Inadequate effect of product 609 5.4% Change in blood sugar 113 1.0% Somnolence 63 0.6% Cognitive change 51 0.5% Constipation/diarrhea 42 0.4% Nausea/vomiting 40 0.4% Excessive side effects 37 0.3% Respiratory distress 12 0.1% Edema 12 0.1% Fall 11 0.1% Headache 6 0.1% Visual disturbance 6 0.1% Gastrointestinal bleed 3 0.0% Hearing disturbance 0 0.0% Aspiration 0 0.0% Cardiac arrest 0 0.0% Death 0 0.0% TOTAL RESPONSES 11,285 100.0% 4

Type of Error FIGURE 4: TYPE OF ERRORS Dose omission Wrong dosage Extra dose Wrong drug Under dose Wrong strength Wrong time Overdose Expired order Monitoring Error Wrong patient Wrong duration Wrong technique Wrong route Wrong rate Expired product 0 1,000 2,000 3,000 4,000 5,000 6,000 7,000 F. POSSIBLE CAUSES Number of Responses The respondents were asked to identify possible causes of the errors, with multiple responses permitted (Figure 5). Human factors and communication were listed as the two main possible causes for the medication errors, at 53.3% and 40.2% respectively, which accounts for over 93% of the responses in this category. High staff turnover, heavy use of agency nurses, understaffing and lack of communication between staff on site are possible underlying factors in explaining communication and human factor issues. Areas that we anticipated might be associated with a large number of errors, and that technological and other interventions often address such as Nursing Home Medication Error Quality Initiative (MEQI) variance, with 49.7% of responses, was dose omission. Another 22.6% reported variances related to dosage: wrong dosage - wrong form of medication (7.1%); extra dose multiple doses given at one administration point (6.7%); under dose too little medication given (4.8%); and overdose too much medication given (4.0%). These two general categories ( dose omission and incorrect dose ) account for 72.3% of all responses, with the following categories also having over 4%: wrong drug (6.4%); wrong strength (4.3%); and wrong time (4.3%). medication name confusion, labeling, packaging design and pharmacy closed account for a very limited number of reported errors. G. PHASE IN MEDICATION PROCESS Sites were asked to characterize the phase in the medication use process at which errors occurred: prescribing, documenting, administering, or monitoring. Multiple responses were permitted. Most of the responses were in the administration phase (56.2%), followed by the documentation phase (37.4%). We saw only 3.4% of errors reported in the phase of prescribing, and monitoring accounted for only 3.0% of responses. Number of Responses 7,000 6,000 5,000 4,000 3,000 2,000 1,000 FIGURE 5: POSSIBLE CAUSES 0 Human factors Communication Labeling Med. name confusion Packaging design Pharmacy closed FIGURE 6: PERSONNEL INVOLVED Physician 4.3% Pharmacist 6.9% Registered nurse 29.4% Patient or caregiver 2.3% Support personnel 2.1% Licensed practical nurse 54.0% Nurse Practioner, Physician Assistant and Student had values of <1.0% H. PERSONNEL INVOLVED The respondents were asked to identify personnel involved, with multiple responses permitted (Figure 6). Licensed practical nurses (54.0% of responses) or registered nurses (29.4% of responses) were involved in most errors. This is to be expected as licensed practical nurses (LPNs) and registered nurses provide most of the direct patient care and delivery of medications at nursing homes, with LPNs doing the bulk of this care. Pharmacists were involved in 6.9% of errors and physicians in 4.3% of errors. 5

Nursing Home Medication Error Quality Initiative (MEQI) I. CONTRIBUTING FACTORS Nursing homes were asked to provide information identifying all possible factors that contributed to the error, and again multiple responses were allowed (Table 3). Responses under primary contributing factors were: frequent distractions (40.8%); policies and procedures (17.3%); and workload increase (10.2%). J. MEDICATIONS INVOLVED Nursing Homes were asked to list the most frequent ten medications that were involved in errors at their site, and the number of error incidents with that medication. If a home observed more than ten errors they were asked to list those medications that were repeatedly involved, or that caused the most serious type of errors. The list was limited to ten per site to reduce the reporting burden for nursing homes, and to limit the medication list. Facilities reported more than 2900 incidents, with about 400 different types of generic medications. The five most frequently reported medications involved in errors were: lorazepam (Ativan), warfarin sodium (Coumadin), insulin (all types), hydrocodone combinations (Vicodan, Lortab) and furosemide (Lasix) (Table 4). No. INCIDENTS MEDICATION GENERIC NAME TABLE 3: CONTRIBUTING FACTORS Contributing Factors No. of Responses CLASS OF DRUG BENZODIAZEPINE(TRANQUILIZER), ANTICONVULSANT Percent Responses Frequent distractions 5,149 40.8% Policies and procedures 2,185 17.3% Workload increase 1,287 10.2% Inadequate information 923 7.3% Contract staff 904 7.2% Pharmacy dispensing 776 6.2% Improper training 583 4.6% Shift change 372 2.9% Illegible handwriting 299 2.4% Emergency situation 79 0.6% Poor lighting 57 0.5% TOTAL RESPONSES 12,614 100.0% TABLE 4: MOST FREQUENT MEDICATIONS BRAND NAME (S) EXAMPLES 457 LORAZEPAM ATIVAN 349 WARFARIN SODIUM ANTI-COAGULANT COUMADIN 332 INSULIN (ALL TYPES) ANTI-DIABETIC HUMULIN, LISPRO, 233 HYDROCODONE COMBINATIONS NARCOTIC ANALGESIC VICODAN, NORCO 173 FUROSEMIDE DIURETICS, LOOP LASIX 150 FENTANYL PATCH NARCOTIC ANALGESIC DURAGESIC 130 ALPRAZOLAM BENZODIAZEPINE(TRANQUILIZER), ANTICONVULSANT XANAX 126 OXYCODONE NARCOTIC ANALGESIC OXYCONTIN 102 SENNA LAXATIVES, STIMULANT 94 CLONAZEPAM BENZODIAZEPINE(TRANQUILIZER), ANTICONVULSANT KLONOPIN 86 QUETIAPINE ANTI-PSYCHOTIC SEROQUEL 86 ACETAMINOPHEN ANALGESIC TYLENOL 80 OLANZAPINE ANTI-PSYCHOTIC ZYPREXA 74 DIGOXIN DIGITALIS PREPARATION LANOXIN 73 PHENYTOIN ANTI-CONVULSANT DILANTIN 69 RISPERIDONE ANTI-PSYCHOTIC RISPERDAL 68 MORPHINE NARCOTIC ANALGESIC MSIR 65 OXYCODONE AND ACETAMINOPHEN NARCOTIC ANALGESIC PERCOCET 64 NITROGLYCERIN PATCH ANTI-ANGINAL NITRO-DUR 63 POTASSIUM CHLORIDE MINERAL SUPPLEMENT TABLE 5: MOST FREQUENT CLASSES OF MEDICATIONS No. INCIDENTS CLASS OF MEDICATIONS 855 NARCOTIC ANALGESIC 747 BENZODIAZEPINE (TRANQUILIZER), ANTICONVULSANT 394 ANTICOAGULANT 364 ANTIDIABETIC (INCLUDING SULFONYLUREA) 329 ANTIBACTERIAL 248 ANTIPSYCHOTIC 224 LAXATIVE (STIMULANT, HYPEROSMOTIC, SOFTENER/LUBRICANT) 199 DIURETICS, LOOP 195 ANTIDEPRESSANT(INCLUDING ANTIOBSESSIONAL, ANTIANXIETY) 159 ANTIANGINAL (INCLUDING CALCIUM CHANNEL BLOCKER) 152 ANALGESIC, ANTI-INFLAMMATORY 138 ANTICONVULSANT (INCLUDING ANTIEPILEPTIC) 127 ANTIHYPERTENSIVE (INCLUDING ACE INHIBITOR AND ANGIOTENSIN II RECEPTOR AGONIST) 127 VITAMIN SUPPLEMENT 114 MINERAL SUPPLEMENT 101 ANTIULCER AGENT(INCLUDING PROTON PUMP INHIBITOR AND HISTAMINE H2 ANTAGONIST) 96 ANTIADRENERGIC, ANTI-ANGINAL, ANTI-ARHYTHMIC, ANTI-HYPERTENSIVE 81 NUTRITIONAL SUPPLEMENT 74 DIGITALIS PREPARATION 73 OSTEOPOROSIS THERAPY The groups or classes of medications observed the most include: narcotic analgesics, benzodiazepines, anticoagulants, antidiabetics, anti-bacterials, and anti-psychotics (Table 5). We did not collect or have access to comparison data on the frequency of the medications actually provided to nursing home residents during this period. 6

Nursing Home Medication Error Quality Initiative (MEQI) VI. CONCLUSION AND RECOMMENDATIONS In the first year of the MEQI, we expected data inconsistencies because of newly developed tools and inconsistencies in initial response patterns as the nursing homes became familiar with the reporting process. However, information from the nine months of data that were collected has already proved fruitful in suggesting useful procedural changes that may enhance the effectiveness of medication delivery to nursing home patients. We expect that the data will improve during the upcoming years as sites become familiar with the process and comfortable sharing their data without fear of punitive action. The following are some recommendations to facilities, based on the data received during the annual report process: Nursing homes are encouraged to use this report to focus attention within their facility on medication errors and ensure their medication management advisory committee is active. Medication management advisory committees should consider training and providing information to the facility staff members on the definition of a medication error. It is recommended that all errors be reported and recorded, even if considered insignificant. A non-punitive atmosphere in facilities regarding identifying and reporting medication errors will facilitate more consistent reporting across sites. Medication management advisory committees are advised to focus on: instituting policies and procedures to reduce the number of errors related to frequent distractions; addressing communications and human factors; and putting policies into place that provide checks and balances and ensure that these issues do not lead to medication errors. Medication management advisory committees at sites with a large number of dose omissions need to develop or revise policies and procedures to ensure that all patients get their medications when needed. We recommend that nursing home physicians and pharmacists review all nursing home patients medications lists to ensure that if patients are on medications, or combinations of medications, listed in the Beers criteria 1 that their use is clearly indicated and justified. Beers criteria medications are those included in a consensus panel report identifying medications that are inappropriate or problematic when used in the elderly. 1 Donna M. Fick; James W. Cooper; William E. Wade; Jennifer L. Waller; J. Ross Maclean; Mark H. Beers. Updating the Beers Criteria for Potentially Inappropriate Medication Use in Older Adults: Results of a US Consensus Panel of Experts Arch Intern Med. 2003; 163:2716-2724. Supported by the North Carolina Department of Health and Human Services, Division of Facilities Services contract # 04-9738. For more information contact: Charlotte Williams, 919-966-7927, meqi@shepscenter.unc.edu. 7

NURSING HOME MEDICAL ERROR QUALITY INITIATIVE (MEQI) January 1, 2004 to September 30, 2004 Medication Error Quality Initiative Cecil G. Sheps Center for Health Services Research The University of North Carolina at Chapel Hill CB# 7590, 725 Airport Road Chapel Hill, NC 27599-7590 http://www.shepscenter.unc.edu